Global Needle-free Diabetes Care Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Needle-free Diabetes Care is a cutting-edge technology that is currently being developed. And this device will allow the people with diabetes to measure the level of blood sugar without having to stick needed in the fingertip. Continuous glucose monitors and insulin pumps are the finest choices available today for automating the majority of the complicated daily process of blood sugar management. The increasing prevalence of diabetes, increasing geriatric population and strategic development between hospitals has led the adoption of Needle-free Diabetes Care across the forecast period. According to International Diabetes Federation, total adult population in Spain is 34,538,600 in year 2020 and around 10.5 % of this had diabetes that is 3,619,100 adults had diabetes. Also, with the increasing prevalence of geriatric population, the adoption & demand for Needle-free Diabetes Care is likely to increase the market growth during the forecast period. However, high cost associated with the facility impedes the growth of the market over the forecast period of 2022-2028.
The key regions considered for the Global Needle-free Diabetes Care Market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. Because of the huge diabetic population, changing lifestyles, rising healthcare costs, and an increase in the number of obese persons, North America dominates the Needle-free Diabetes Care industry. Because of the increasing government funding for diabetes management in the region, Asia-Pacific is predicted to expand at the quickest rate throughout the forecast period of 2022 to 2028.
Major market player included in this report are:
Bioject Medical Technologies Inc.
Valeritas, Inc.
Antares Pharma
Endo International plc
InsuJet
PharmaJet
PenJet
INJEX
Technologies Medicales Internationales (MIT Canada) Inc.
Needle Free Injection System
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Devices Types:
Treatment Devices
Diagnostic Devices
By Treatment:
Oral Insulin
Inhaled Insulin
Insulin Patch
Others
By Application:
Insulin Delivery
Other
By End Users:
Diagnostic Centers
Hospitals & Clinics
Other
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Needle-free Diabetes Care Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
- 1.2.1. Global Needle-free Diabetes Care Market, by Region, 2020-2028 (USD Billion)
- 1.2.2. Global Needle-free Diabetes Care Market, by Devices Types, 2020-2028 (USD Billion)
- 1.2.3. Global Needle-free Diabetes Care Market, by Treatment, 2020-2028 (USD Billion)
- 1.2.4. Global Needle-free Diabetes Care Market, by Application, 2020-2028 (USD Billion)
- 1.2.5. Global Needle-free Diabetes Care Market, by End Users, 2020-2028 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Needle-free Diabetes Care Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Needle-free Diabetes Care Market Dynamics
- 3.1. Needle-free Diabetes Care Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. Increasing prevalence of diabetes
- 3.1.2. Market Challenges
- 3.1.2.1. High cost associated with the facility
- 3.1.3. Market Opportunities
- 3.1.3.1. Increasing geriatric population
Chapter 4. Global Needle-free Diabetes Care Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Needle-free Diabetes Care Market, by Devices Types
- 6.1. Market Snapshot
- 6.2. Global Needle-free Diabetes Care Market by Devices Types, Performance - Potential Analysis
- 6.3. Global Needle-free Diabetes Care Market Estimates & Forecasts by Devices Types 2019-2028 (USD Billion)
- 6.4. Needle-free Diabetes Care Market, Sub Segment Analysis
- 6.4.1. Treatment Devices
- 6.4.2. Diagnostic Devices
Chapter 7. Global Needle-free Diabetes Care Market, by Treatment
- 7.1. Market Snapshot
- 7.2. Global Needle-free Diabetes Care Market by Treatment, Performance - Potential Analysis
- 7.3. Global Needle-free Diabetes Care Market Estimates & Forecasts by Treatment 2019-2028 (USD Billion)
- 7.4. Needle-free Diabetes Care Market, Sub Segment Analysis
- 7.4.1. Oral Insulin
- 7.4.2. Inhaled Insulin
- 7.4.3. Insulin Patch
- 7.4.4. Others
Chapter 8. Global Needle-free Diabetes Care Market, by Application
- 8.1. Market Snapshot
- 8.2. Global Needle-free Diabetes Care Market by Application, Performance - Potential Analysis
- 8.3. Global Needle-free Diabetes Care Market Estimates & Forecasts by Application 2019-2028 (USD Billion)
- 8.4. Needle-free Diabetes Care Market, Sub Segment Analysis
- 8.4.1. Insulin Delivery
- 8.4.2. Other
Chapter 9. Global Needle-free Diabetes Care Market, by End Users
- 9.1. Market Snapshot
- 9.2. Global Needle-free Diabetes Care Market by End Users, Performance - Potential Analysis
- 9.3. Global Needle-free Diabetes Care Market Estimates & Forecasts by End Users 2019-2028 (USD Billion)
- 9.4. Needle-free Diabetes Care Market, Sub Segment Analysis
- 9.4.1. Diagnostic Centers
- 9.4.2. Hospitals & Clinics
- 9.4.3. Other
Chapter 10. Global Needle-free Diabetes Care Market, Regional Analysis
- 10.1. Needle-free Diabetes Care Market, Regional Market Snapshot
- 10.2. North America Needle-free Diabetes Care Market
- 10.2.1. U.S. Needle-free Diabetes Care Market
- 10.2.1.1. Devices Types breakdown estimates & forecasts, 2019-2028
- 10.2.1.2. Treatment breakdown estimates & forecasts, 2019-2028
- 10.2.1.3. Applications breakdown estimates & forecasts, 2019-2028
- 10.2.1.4. End Users breakdown estimates & forecasts, 2019-2028
- 10.2.2. Canada Needle-free Diabetes Care Market
- 10.3. Europe Needle-free Diabetes Care Market Snapshot
- 10.3.1. U.K. Needle-free Diabetes Care Market
- 10.3.2. Germany Needle-free Diabetes Care Market
- 10.3.3. France Needle-free Diabetes Care Market
- 10.3.4. Spain Needle-free Diabetes Care Market
- 10.3.5. Italy Needle-free Diabetes Care Market
- 10.3.6. Rest of Europe Needle-free Diabetes Care Market
- 10.4. Asia-Pacific Needle-free Diabetes Care Market Snapshot
- 10.4.1. China Needle-free Diabetes Care Market
- 10.4.2. India Needle-free Diabetes Care Market
- 10.4.3. Japan Needle-free Diabetes Care Market
- 10.4.4. Australia Needle-free Diabetes Care Market
- 10.4.5. South Korea Needle-free Diabetes Care Market
- 10.4.6. Rest of Asia Pacific Needle-free Diabetes Care Market
- 10.5. Latin America Needle-free Diabetes Care Market Snapshot
- 10.5.1. Brazil Needle-free Diabetes Care Market
- 10.5.2. Mexico Needle-free Diabetes Care Market
- 10.6. Rest of The World Needle-free Diabetes Care Market
Chapter 11. Competitive Intelligence
- 11.1. Top Market Strategies
- 11.2. Company Profiles
- 11.2.1. Bioject Medical Technologies Inc.
- 11.2.1.1. Key Information
- 11.2.1.2. Overview
- 11.2.1.3. Financial (Subject to Data Availability)
- 11.2.1.4. Product Summary
- 11.2.1.5. Recent Developments
- 11.2.2. Valeritas, Inc.
- 11.2.3. Antares Pharma
- 11.2.4. Endo International plc
- 11.2.5. InsuJet
- 11.2.6. PharmaJet
- 11.2.7. PenJet
- 11.2.8. INJEX
- 11.2.9. Technologies Medicales Internationales (MIT Canada) Inc.
- 11.2.10. Needle Free Injection System
Chapter 12. Research Process
- 12.1. Research Process
- 12.1.1. Data Mining
- 12.1.2. Analysis
- 12.1.3. Market Estimation
- 12.1.4. Validation
- 12.1.5. Publishing
- 12.2. Research Attributes
- 12.3. Research Assumption